Dais Newsfeed | 21/04/2022 05:51 PM | Click to read full article
India’s drug regulator – on Thursday recommended the use of Biological E’s Corbevax in children aged 5-12 years as reported by News18 earlier. The panel met at noon to discuss data and the use of the vaccine in children in that age bracket.
The recommendations have now been sent to the Drug Controller General of India by the SEC. A nod by the DCGI is now awaited before the Union Health Ministry gives a final go-ahead.